Drugs / JKN2301
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07357051 | Nov 2025 → Jan 2026 overdue | viral respiratory tract infection | Joincare Pharmaceutical Group Industry Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JKN2301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07357051 ↗ |
| Route | Oral | “Single oral dose, administered according to a weight-tiered dosing scheme.” NCT07357051 ↗ |